Investor Backing & Capital Strength:
Capital momentum includes a $100M Series D in July 2024 at a higher valuation, signaling strong support for continued expansion. The raise is characterized as a notable step-up in a challenging health-tech funding climate.
Market Expansion:
Geographic and payer reach are widening with nationwide availability and announced rollouts into Medicare Advantage by late 2024 and Medicaid in 2025. Broader plan connectivity and integrated primary care referral pathways indicate growth beyond the original commercial focus.
Strong Revenue Growth:
Revenue is described as more than doubling over the prior 12 months alongside rising appointment volume and a rapidly expanding provider network. Milestones such as 1,000,000+ patients connected and millions of care hours delivered reinforce throughput growth.
